Though distinct in terms of pathology, natural history and therapeutic approach, irritable
bowel syndrome (IBS) and inflammatory bowel disease (IBD) have some features in …

Abstract Purpose of Review Post-infectious irritable bowel syndrome (PI-IBS) is
characterized by persistent abdominal pain and diarrhea, typically following an episode of …

The clinical spectra of irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD)
intersect to form a scantily defined overlap syndrome, termed pre-IBD. We show that …

Background Symptoms of inflammatory bowel disease (IBD) often overlap with those of
irritable bowel syndrome (IBS). Aim To evaluate the diagnostic performance of faecal …

Background Assessing the inflammation is important in the follow-up of paediatric patients
with inflammatory bowel disease (IBD). We aim to evaluate the value of B cell-activating …

The symptom-based diagnosis of irritable bowel syndrome (IBS) has not been established in
everyday clinical practice, and the diagnosis of this disorder remains one of exclusion. It has …

Emerging evidence demonstrates that microRNAs (miRNAs) could serve as reliable
biomarkers of inflammation and oncogenesis. The aim of this study was to determine …

Background Fecal calprotectin, an indicator of colonic inflammation, is associated with
nonconstipated irritable bowel syndrome. Rifaximin is an antibiotic used to treat …

Background Low‐grade inflammation occurs in some patients with irritable bowel syndrome
(IBS). However, the exact inflammatory markers of IBS and the relationship of these markers …

Irritable bowel syndrome (IBS) is one the most frequent and common functional
gastrointestinal disorders that has a multifactorial etiopathogenesis. Multiple biomarkers …